Blog
Donate
Blog
Donate
Patients & Caregivers
Let Us Support You
What is AE?
Symptoms
Diagnosis
Treatment
Recovery
Living with AE
Professionals
How We Can Support You
Join the Clinicians Network
Attend AEA Provider Monthly Education Series
Provider Resources
Research
Research In AE
Apply for a Grant
AEA Research Network
Make a Difference
AE Today
AE Tomorrow
How Can You Help?
News & Support
News
Support
Media Kit
About
AE Alliance
Living with AE Advisory Council
Staff
Board of Directors
Medical Advisory Board
Financials
Blog
Contact
Search
Clinical manifestations and outcomes of the treatment of patients with GABAB encephalitis
February 27, 2021
https://pubmed.ncbi.nlm.nih.gov/24662003/
by
aealliance
Research
Resources
A novel NREM and REM parasomnia with sleep breathing disorder associated with antibodies against IgLON5: a case series, pathological features, and characterization of the antigen
Encephalitis associated with autoantibodies binding to γ-aminobutyric acid-A, γ-aminobutyric acid-B and glycine receptors: immunopathogenic mechanisms and clinical characteristics
